CareFlite Cut Prescription Spending by 40 Percent – Here’s How

CareFlite is used to saving lives in the most dire of situations, but the Grand Prairie nonprofit has also been saving on their healthcare spend. By focusing on prescription drugs, the company has saved hundreds of thousands each year on prescriptions alone. Prescriptions can represent 18 to 23 percent of total healthcare spending for companies, even though only a few years ago the took up only 10 percent of healthcare spending. In 2016, CareFlite spent $863,000 on prescriptions alone for its 660 employees. But three years ago, partially-insured CareFlite moved to an independent pharmacy benefit manager with the help of… Full Story

Local Infusion Software Company Expands in Pennsylvania

Dallas and Austin-based software start-up WeInfuse has expanded its client base to the Infusion Center of Pennsylvania, an independent, multi-specialty infusion center with two locations in Southeastern Pennsylvania. WeInfuse manages the workflow of infusions centers, adding data analytics, medication inventory management, and space optimization for a number of centers that treat immune disorders all over the country. The software has been used at over 100 infusion centers and has supported 65,000 infusion treatments. “We provide superior service to our patients, and expect the same from our vendors,” said ICPA’s COO, Phil Weber via release. “We think every infusion center in… Full Story

A North Texas Partnership to Fight Chronic Pain with Ketamine

Principal Spine and Pain Consultants have partnered with Kalypso Wellness Centers to bring ketamine infusion therapies to North Texas to fight chronic pain. According to the CDC, 50 million Americans suffer from chronic pain and depression affects about 16 million American adults every year. Ketamine has a long history of being used in the operating room during surgery and has been included on the World Health Organization’s most essential medicines. More recent studies show that ketamine can treat depression, anxiety, bipolar, PTSD, pain, inflammation as well as migraines and headaches. Ketamine works to counteract these health issues by working on several… Full Story

The Federal Suit Against Medoc’s Alleged Fraud Scheme

After the FBI raided the Medoc Health Services offices last year, the federal government is pursuing a lawsuit against the Dallas-based pharmacy services provider for false claims and kickbacks. The claim alleges that Medoc received around $2 million from North Texas pharmacies for sending prescriptions their way through affiliated physicians. Shawn Shinneman wrote about the original scandal after he was contacted by employees ready to describe the impropriety. You can read the most recent update over on D Magazine’s site. Check it out here.

McKesson Named in Nationwide Opioid Lawsuit

McKesson Corp. has been named in a Cleveland lawsuit against many of the largest players in the pharmaceutical industry, the Washington Post reports. The filing describes the drug companies as solely focused on profits at the cost of the damage done to country by opioids. The companies say they should not be charged with second guessing the expertise of doctors who prescribe the pills. The case consolidates claims from around the country, and because of documents released by a three judge panel last week, the direction and quantity of drugs is better able to be tracked between manufacturers, distributors, and… Full Story

UNTHSC Researcher Will Lead National Opioid Crisis Steering Committee

Scott Walters has been named Steering Committee Chair of the HEALing Communities Study, an aggressive effort to find solutions that will put a stop to the national opioid crisis. Walters is Regents Professor and Chair of Health Behavior at the UNT Health Science Center School of Public Health. The study is a part of the National Institutes of Health HEAL (Helping to End Addiction Long-Term) Initiative, which is currently backed by more than $350 million in support. “My role as Steering Committee Chair will be like that of a stage manager,” says Walters, per release. “To keep track of all aspects… Full Story

Physician Dispensing in Texas Heads to Court

The 86th Texas Legislative Session came to an end without any movement on physicians’ ability to expense a limited number of common prescription drugs, so two Texas doctors are taking their case to the Travis County Civil District Court, where they are claiming the ban on physician dispensing is unconstitutional. Texas is out of step with the rest of the nation when it comes to the rule, as it is just one of five states to ban physicians from dispensing anything but free samples to their patients, though the state does allow doctors to dispense medications if they live more than… Full Story

McKesson Appoints New Independent Director to Board

The board of directors at McKesson Corp. elected Ken Washington, the chief technology officer at Ford Motor Company, as a new independent director. This will increase the board from nine to ten members, nine of which are independent. Washington leads Ford’s research, development, and implementation of the company’s technological innovations all around the world. He previously served as vice president of the Advanced Technology Center at Lockheed Martin Space Systems Company, and also built Lockheed’s privacy program. He has also worked in Sandia National Laboratories in New Mexico. “Ken’s years of experience in technology, research, and privacy strategy at complex global organizations… Full Story

Former Pharmacist Gets Two Years and $7 Million in Kickback Scheme

After pleading guilty to his role in a pharmacy kick-back scheme last year, federal court sentenced ex-pharmacist Ravi Morisetty to two years in federal prison and $7 million in restitution, according to the Dallas Morning News. The former Irving pharmacist was part of a scheme that defrauded the military insurance program of more than $100 million, and is the first of 13 defendants to be sentenced in the Trilogy Pharmacy case. DMN reports that Morisetty admitted to paying Trilogy’s marketers around $400,000 to funnel patients to Alpha Pharmacy, which he owned. Morisetty admitted to paying kickbacks to owners of a… Full Story

Merck’s $2 Billion Acquisition of Dallas-based Peloton Therapeutics

Local clinical-stage biopharmaceutical company Peloton Therapeutics is being acquired by pharmaceutical giant Merck for an upfront payment of $1.05 billion just as the company was about to go public. Peloton shareholders may receive $1.15 billion more if regulatory and sales milestones are met. Peloton Therapeutics focuses on novel medications for patients with cancer and other life-threatening conditions and is developing a new oral treatment to target late-stage renal cell carcinoma, showing signs of anti-tumor activity in clinical studies. The company raised $150 million in Series E funding in February. Peloton was founded by UT Southwestern scientists with an $11 million grant… Full Story